Given the recent appointments in management coupled with IMU collaboration and now only less than a year out from trials this could be a turning point for the stock.
whatever they do the raise at i bet it will be tightly held post raise.
looking back at recent lows there has been a buyer mopping up @ 2 cents .. last raise was done at 3.8 cents back last year in Feb.
could be worth a punt with little selling up to 3.8.. not bad risk reward @ circa $16m mkt cap.
almost @ shell valuation for a biotech.
Given the recent appointments in management coupled with IMU...
-
- There are more pages in this discussion • 28 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add ALA (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
14.5¢ |
Change
-0.005(3.33%) |
Mkt cap ! $152.5M | |||
| Open | High | Low | Value | Volume |
| 15.0¢ | 15.0¢ | 14.5¢ | $38.90K | 263.2K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 5 | 624656 | 14.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 15.0¢ | 628807 | 7 |
View Market Depth
| Last trade - 16.10pm 30/08/2024 (20 minute delay) ? |
| ALA (ASX) Chart |